The Effectiveness and Safety of Romosozumab and Teriparatide in Postmenopausal Women with Osteoporosis.
Martin C HartzFabian B JohannessenTorben HarsløfBente Lomholt LangdahlPublished in: The Journal of clinical endocrinology and metabolism (2024)
Treatment with romosozumab yields larger increases in bone mineral density than teriparatide after 12 months and a higher rate of completion.